Laureate Education Reports Financial Results for The Third Quarter And Nine Months Ended September 30, 2026

Laureate posts strong Q3 growth and boosts share buyback by $150 million.

What the company is saying

Laureate Education, Inc. reports a 21% year-over-year revenue increase for Q3 2026, reaching $485.1 million, and a 9% rise in new enrollments for the nine months ended September 30, 2026. The company highlights that operating income jumped to $119.1 million and net income to $101.2 million for the quarter, attributing the net income surge to both higher operating income and a discrete $25.4 million tax benefit. Adjusted EBITDA climbed to $146.8 million, with management explicitly noting that $26 million of this was due to academic calendar timing. CEO Eilif Serck-Hanssen emphasizes strong enrollment intakes in Mexico and Peru, the successful launch of a new campus in Puebla, and growth in online offerings in Peru. The company announces a $150 million increase to its share repurchase program, citing favorable operating momentum and a strong balance sheet. Laureate reaffirms its full-year 2026 outlook, projecting continued growth in enrollments, revenue, Adjusted EBITDA, and EPS.

What the data suggests

The disclosed numbers indicate robust financial and operational momentum. Q3 2026 revenue rose 21% to $485.1 million, with constant currency growth at 14% and a $29 million boost from academic calendar timing. Operating income increased by $47.6 million to $119.1 million, and net income nearly tripled to $101.2 million, aided by a $25.4 million tax benefit. Adjusted EBITDA rose to $146.8 million, up $52 million year-over-year, with $26 million attributable to timing effects. For the nine months ended September 30, 2026, revenue grew 18% to $1,373.6 million, operating income reached $315.0 million, and net income was $216.7 million, almost double the prior year. Enrollment growth was broad-based: new enrollments up 9%, total enrollments up 6%, with Mexico and Peru both contributing. The company repurchased $256 million of stock year-to-date, and with the new $150 million authorization, can now repurchase up to $225.2 million more. Cash stood at $189.9 million and net debt at $14.3 million as of September 30, 2026. The company expects calendar timing benefits to reverse in Q4 and maintains full-year guidance: $1,920–$1,930 million revenue, $593–$599 million Adjusted EBITDA, and $2.04–$2.10 Adjusted EPS. Disclosures are comprehensive, with clear attribution of one-time items and timing effects.

Analysis

The announcement is highly factual, with the majority of claims supported by realised, audited financial and operational results for both the third quarter and nine months ended September 30, 2026. Key profitability metrics (operating income, net income, Adjusted EBITDA, EPS) are disclosed alongside revenue and enrollment growth, satisfying the requirements for a strong_positive signal. The only forward-looking elements are the reaffirmed 2026 outlook and the expectation that academic calendar timing impacts will be offset in Q4, both of which are standard and proportionate in tone. There is no evidence of narrative inflation or exaggerated claims; the language is measured and directly tied to disclosed results. The capital allocation update (share repurchase authorization increase) is a realised board action, not a speculative capital outlay with uncertain returns. All major financial and operational metrics are transparent, and the benefits of reported actions are either already realised or expected within the current fiscal year.

Risk flags

• ●A material portion of Q3 and year-to-date revenue and Adjusted EBITDA growth is attributable to academic calendar timing, which will reverse in Q4, potentially leading to less favorable sequential comparisons.
• ●The $25.4 million discrete tax benefit significantly boosted net income for Q3 and the nine-month period, representing a one-time item that will not recur in future quarters.
• ●Currency fluctuations remain a risk, as constant currency revenue growth was 14% versus 21% reported in Q3, and future results may be affected by FX volatility, especially given operations in Mexico and Peru.
• ●The increased share repurchase authorization commits additional capital to buybacks, which may limit flexibility for other investments if market or operating conditions change.
• ●Forward-looking guidance assumes continued enrollment and revenue growth, but any slowdown in student demand or macroeconomic deterioration in Mexico or Peru could impact results.

Bottom line

Laureate delivered strong Q3 and year-to-date results, with revenue, operating income, and net income all showing double-digit growth, though part of this was due to academic calendar timing and a one-time tax benefit. The company is aggressively returning capital to shareholders, having repurchased $256 million of stock so far in 2026 and increasing its buyback authorization by $150 million, with $225.2 million now available for future repurchases. Operational momentum is evident in both Mexico and Peru, with robust enrollment growth and a successful new campus launch. The balance sheet remains solid, with low net debt and ample cash. Investors should be aware that some of the reported growth will reverse in Q4 as timing effects unwind, and that future net income may not benefit from similar tax items. The most important takeaway is that Laureate is executing well on both growth and capital return, but normalized Q4 results will be a key test of underlying momentum.

Announcement summary

(NASDAQ:LAUR) Laureate Education, Inc., which operates five higher education institutions across Mexico and Peru, announced its financial results for the third quarter and nine months ended September 30, 2026. For the third quarter of 2026, reported revenue increased 21% to $485.1 million, with constant currency revenue up 14% and favorably affected by approximately $29 million of intra-year academic calendar timing. Operating income for the quarter was $119.1 million, up from $71.5 million in the prior year period. Net income for the third quarter was $101.2 million, compared to $34.4 million in the third quarter of 2025, with the increase mainly driven by higher operating income and a discrete tax benefit of $25.4 million. Adjusted EBITDA for the third quarter was $146.8 million, compared to $94.8 million in the prior year, and was favorably affected by approximately $26 million of intra-year academic calendar timing. Basic and diluted earnings per share for the third quarter were $0.74 and $0.73, respectively. For the nine months ended September 30, 2026, new enrollments increased 9% and total enrollments increased 6%. New and total enrollments in Peru increased 10% and 5%, respectively, while in Mexico they increased 8% and 6%, respectively. Reported revenue for the nine months was $1,373.6 million, up 18% or $213.1 million from the prior year, with constant currency revenue up 8% and favorably affected by approximately $20 million of intra-year academic calendar timing. Operating income for the nine months was $315.0 million, compared to $251.6 million in the prior year. Net income for the nine months was $216.7 million, compared to $112.3 million in the prior year, with the increase driven by higher operating income, foreign currency exchange effects, and a discrete tax benefit of $25.4 million. Adjusted EBITDA for the nine months was $395.1 million, compared to $314.7 million in the prior year, and was favorably affected by approximately $17 million of intra-year academic calendar timing. Basic and diluted earnings per share for the nine months were $1.55 and $1.54, respectively. As of September 30, 2026, Laureate had $189.9 million in cash and cash equivalents, gross debt of $204.2 million, and net debt of $14.3 million. The company repurchased approximately $256 million of its common stock during the nine months ended September 30, 2026, and had $75.2 million of stock repurchase authorization remaining as of that date. On October 29, 2026, Laureate's board approved a $150 million increase to its stock repurchase program, bringing the total authorization to approximately $225.2 million with no fixed expiration date. As of September 30, 2026, Laureate had 135.7 million total shares outstanding. For fiscal 2026, Laureate reaffirmed its outlook, expecting total enrollments in the range of 518,000 to 523,000 students (growth of 4%-5% versus 2025), revenues in the range of $1,920 million to $1,930 million (growth of 13% as-reported and 6%-7% constant currency), Adjusted EBITDA in the range of $593 million to $599 million (growth of 14%-15% as-reported and 8%-9% constant currency), and Adjusted EPS in the range of $2.04 to $2.10 (growth of 19%-22% as-reported). The company expects the intra-year academic calendar timing impacts on revenue and Adjusted EBITDA to be offset in the fourth quarter of 2026. Eilif Serck-Hanssen, President and Chief Executive Officer, highlighted strong new enrollment intakes in both Mexico and Peru, the successful launch of a new campus in Puebla, and continued growth in online capabilities in Peru. The company will host an earnings conference call on October 29, 2026, at 8:30 am ET.

Disagree with this article?